Clinical trials
Other Cancer clinical trials
Below are recruiting other cancer clinical trials, each written for real people, not researchers. We’re tracking 12,892 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT03366116RecruitingPhase 1
Testing an epigenetic drug for advanced solid tumors
This early-phase study tests Aza-TdC in adults with advanced solid cancers that have grown despite standard treatment, or for which no standard options exist. The goal is to see if the drug can be given safely and start to show signs of benefit against tumors.
Bethesda, MarylandAges 18–120 - NCT07798947RecruitingPhase 2
A new combination for limited-stage small cell lung cancer
This trial studies a combination of two experimental drugs for people with limited-stage small cell lung cancer that hasn't gotten worse after standard treatment with chemotherapy and radiation. The goal is to see if this combination can help control the cancer for a longer time.
Jinan, ShandongAges 18–75 - NCT07094750Recruiting
Comparing treatment intensities for less fit adults with AML
This study compares different treatment intensities for adults with acute myeloid leukemia (AML) who are less able to handle strong chemotherapy. It aims to find the best approach for people with health issues like heart or lung problems that make standard chemo riskier.
Seattle, WashingtonAges 18 years+ - NCT07875582Recruiting
Blood test for better pancreatic cancer diagnosis
This study looks for proteins in the blood that could help doctors tell the difference between pancreatic cancer and non-cancerous pancreatic conditions, such as chronic pancreatitis or benign cysts. By participating, you could help improve early and accurate diagnosis, which may lead to better outcomes for future patients.
IașiAges 18 years+ - NCT05379153RecruitingPhase 3
Laser therapy for vaginal dryness in breast cancer survivors
This trial tests whether laser therapy can help women who have had breast cancer and now experience vaginal dryness. It aims to see if this treatment can reduce dryness and improve comfort.
Des Moines, IowaAges 22 years+ - NCT07631650RecruitingPhase 2
Bevonescein to help surgeons see nerves during thyroid surgery
This study tests a special dye called bevonescein that helps surgeons see nerves better during thyroid removal surgery. The goal is to protect your voice by preventing nerve damage during the procedure.
Pittsburgh, PennsylvaniaAges 18 years+ - NCT07564401RecruitingPhase 1/Phase 2
CAR-T Cell Therapy for Advanced Lung Cancer
This study tests DJI136, a new type of cell therapy that trains your immune cells to fight small cell lung cancer. The therapy targets a protein called DLL3 found on cancer cells. It's designed for patients whose cancer has returned or progressed after initial chemotherapy and immunotherapy.
Lexington, KentuckyAges 18 years+ - NCT04665739RecruitingPhase 2
Lutetium Lu-177 for lung carcinoid tumors with somatostatin receptors
This trial tests lutetium Lu 177 dotatate, a targeted radiation treatment, for advanced lung neuroendocrine (carcinoid) tumors that have a specific marker called somatostatin receptors. It may help shrink tumors by delivering radiation directly to cancer cells that “light up” on a special scan.
Birmingham, AlabamaAges 18 years+ - NCT06022965Recruiting
Telemedicine support for older adults with cancer
This study uses telemedicine (video or phone visits) to help older adults with cancer, especially those in underserved communities, get better care. If you're 65 or older and starting a new cancer treatment, you may be able to join from home in English, Spanish, or Chinese.
Duarte, CaliforniaAges 65 years+ - NCT05350748Recruiting
MDS study using detailed tests on blood and bone marrow
This study carefully evaluates people with myelodysplastic syndromes (MDS) and closely related blood disorders using detailed medical, blood, and bone marrow testing. The goal is to better understand these conditions and how they progress, which may help guide future care.
Bethesda, MarylandAges 1 day–120 years - NCT07646821RecruitingPhase 1/Phase 2
Study of two drugs for leukemia with TP53 mutation
This trial tests combining two drugs, ropeginterferon alfa-2b and azacitidine, for people with myelodysplastic syndrome or acute myeloid leukemia that has a TP53 gene change. The treatment may help control the cancer, and the study includes people who are newly diagnosed or whose disease has not responded to prior therapy.
Houston, TexasAges 18 years+ - NCT07878065RecruitingPhase 3
Art and movement to ease anxiety in children with leukemia
This study tests whether art and movement activities can help reduce anxiety in children aged 8-13 who are being treated for acute lymphoblastic leukemia (a type of blood cancer) and are in the third stage of their treatment plan. If your child feels anxious, this program may help them feel calmer and more supported during treatment.
Cairo, Cairo GovernorateAges 8–13 - NCT06466382Recruiting
Personalized cancer therapy for advanced ovarian cancer
This trial tests whether a treatment plan tailored to your specific tumor and health can work better for advanced ovarian, peritoneal, or fallopian tube cancer. It aims to find the best therapy for each patient to improve outcomes.
Baden, Canton of AargauAges 18 years+ - NCT07878156RecruitingPhase 3
Numbing medicine for children having brain tumor surgery
This study tests whether adding a numbing medicine to the standard pain block can reduce pain after brain surgery in children. It may help children feel more comfortable and recover more smoothly.
CairoAges Up to 18 years - NCT07877285Recruiting
Nutrition and monitoring to prevent confusion after gynecologic cancer surgery
This trial tests whether giving special nutrition before and possibly during surgery, along with careful brain monitoring during anesthesia, can reduce confusion (delirium) after surgery in older women with gynecologic cancer.
Elâzığ, ElâzığAges 65–80 - NCT06907160Recruiting
Genetic testing before lung cancer treatment
This study looks at how tumors respond to chemotherapy plus immunotherapy before surgery for non-small cell lung cancer. It uses genetic tests on the tumor and blood to personalize treatment and possibly improve outcomes.
SeoulAges 19 years+ - NCT06385262RecruitingPhase 2
Chemo before surgery for early-stage lung cancer
This study tests whether giving chemotherapy before surgery helps people with non-small cell lung cancer that has not spread far. The goal is to see if it can shrink the tumor and improve outcomes.
Durham, North CarolinaAges 18 years+ - NCT06028022RecruitingPhase 2
Reishi mushroom for fatigue and joint/muscle pain in breast cancer
This trial tests whether a reishi mushroom extract can help reduce fatigue and joint or muscle pain in people with breast cancer who are taking aromatase inhibitors. If you have these symptoms, you may be able to join.
Albert Lea, MinnesotaAges 18 years+ - NCT07463807RecruitingPhase 1/Phase 2
Comparing two drug combinations for multiple myeloma that returned quickly
This study tests a new combination of two drugs, teclistamab and pomalidomide, against the usual treatment of three drugs for multiple myeloma that has come back shortly after a standard treatment. The goal is to see if the new combination works better or is safer.
Duarte, CaliforniaAges 18 years+ - NCT07870265Recruiting
Blood test for detecting BRAF mutation in melanoma
This trial tests a new blood test to detect a specific gene change (BRAF V600E) in melanoma that has come back. The test uses a technology called CRISPR to find the mutation in a simple blood draw, which could help guide treatment without needing a tissue biopsy.
Brno, BrnoAges 18 years+ - NCT05773274RecruitingPhase 2
Retreating with 177Lu-DOTATATE radiation versus usual treatment
This trial tests whether repeating a targeted radioactive treatment (177Lu-DOTATATE) works better than standard options in people with metastatic gastroenteropancreatic neuroendocrine tumors. It may help by controlling tumor growth after the first round of this therapy stops working.
Birmingham, AlabamaAges 18 years+ - NCT06855524RecruitingPhase 2
Seaweed supplement for less fatigue during chemotherapy
This study tests whether fucoidan, a supplement from brown seaweed, can help reduce fatigue caused by chemotherapy. Doctors at Mayo Clinic want to see if taking fucoidan during chemo helps you feel less tired.
Scottsdale, ArizonaAges 18 years+ - NCT07686445RecruitingPhase 1
Study of AN4035 for advanced cancers with RAS mutations
This trial tests a new drug, AN4035, for people with advanced cancers that have a RAS mutation and high levels of a protein called CEACAM5. The drug may help shrink tumors or slow their growth.
PerthAges 18 years+ - NCT07714980Recruiting
Acupoint stimulation timing for stomach cancer surgery recovery
This trial tests whether giving a gentle, needle-free acupoint stimulation before or after stomach cancer surgery helps speed up recovery. The stimulation uses a small device on the skin, similar to a tens unit, to support recovery after laparoscopic gastrectomy.
Dongying, ShandongAges 18–80
Hear when a new Other Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for other cancer?
- Yes. Clin2 currently lists 12,892 recruiting other cancer studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a other cancer trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a other cancer trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.